We are taking charge of our future

Seeking innovative, disruptive companies that will truly change the lives of those living with diabetes. We encourage patient entrepreneurs and brilliant thinkers who also can execute and deliver to the Market Place. We look for companies that work toward prevention, cures and beyond incremental improvements in the area of diabetes. We participate at a board and advisory board level where we can add strategic and area-specific product development advice.

Below you will find our portfolio companies. Each company in our portfolio fits the descriptions above, and is truly working toward improving the quality of life of those living with diabetes.

Areas of focus: immunology, regenerative medicine, out of the box therapeutics for insulin-dependent diabetes and new business models for compliance

Our Portfolio


AntriaBio is developing a recombinant human basal insulin formulated for once weekly injection, which has the potential to significantly advance the treatment paradigm for insulin replacement therapy.

Dance Biopharm

Dance Biopharm is focused on the development of inhaled insulin products to treat diabetes patients worldwide. The company began operations in 2010 led by Dr. John Patton, who has over 20 years of experience in the development of inhaled insulin.

Diasome Pharmaceuticals

Diasome is developing breakthrough insulin efficacy solutions for people with Type 1 and Type 2 diabetes using hepatocyte targeted nanotechnology-based drug delivery systems.

DiaVacs, Inc.

Diavacs, Inc. is a San Diego-based clinical stage biotechnology company developing products to reverse the onset of Type 1 Diabetes.

One Drop

One Drop is a diabetes management platform that harnesses the power of mobile computing and data science to empower people with diabetes to live healthier lives, together. By logging your daily activities, you can see the relationships that food, insulin, and activity have with glucose levels.


Orgenesis is a development stage company with a novel therapeutic technology that employs a molecular and cellular approach directed at converting a patient’s own liver cells into functional insulin producing cells, as a treatment for diabetes.


Sensulin is developing a true once-a-day glucose-responsive insulin that may mimic a healthy human pancreas. Sensulin may eliminate the need for basal & prandial insulin, offer a substantial improvement in the standard of care, and most importantly, give those with diabetes a chance at a normal life.

Socrates Health Solutions

Socrates Health Solutions is a Delaware based corporation. It is a company committed to applying innovative technology in order to provide affordable healthcare and fitness products, including a non-invasive glucose monitoring device.

Interests - Select all that apply